Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun 1;28(4):taab079.
doi: 10.1093/jtm/taab079.

COVID-19 vaccine passport for safe resumption of travel

Androula Pavli  1 , Helena C Maltezou  2
Affiliations
Editorial

COVID-19 vaccine passport for safe resumption of travel

Androula Pavli et al. J Travel Med. .

Abstract

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues despite the implementation of effective restrictive public health measures, including strict travel restrictions. In light of safe and effective vaccines against COVID-19, ‘vaccine passports’, as a temporary recommendation will facilitate resumption of travel.

Keywords: COVID-19; pandemic; passport; resumption; travel; vaccine.

PubMed Disclaimer

Similar articles

  • COVID-19 and the rise of anti-science.
    Hotez P. Hotez P. Expert Rev Vaccines. 2021 Mar;20(3):227-229. doi: 10.1080/14760584.2021.1889799. Epub 2021 Feb 22. Expert Rev Vaccines. 2021. PMID: 33599568 No abstract available.
  • How can a global pandemic affect vaccine hesitancy?
    Dubé E, MacDonald NE. Dubé E, et al. Expert Rev Vaccines. 2020 Oct;19(10):899-901. doi: 10.1080/14760584.2020.1825944. Epub 2020 Oct 5. Expert Rev Vaccines. 2020. PMID: 32945213 No abstract available.
  • COVID-19 Vaccine and Biologics: An Impending Dilemma.
    Hauptman M, Vasic J, Krase J. Hauptman M, et al. J Drugs Dermatol. 2021 Jan 1;20(1):115-114. doi: 10.36849/JDD.5628. J Drugs Dermatol. 2021. PMID: 33400405
  • Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing Pieces.
    Perosa F, Favoino E, Prete M. Perosa F, et al. Endocr Metab Immune Disord Drug Targets. 2021;21(4):567-568. doi: 10.2174/1871530320666201207234914. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33290205 Review. No abstract available.
  • Recent advances in vaccine and immunotherapy for COVID-19.
    Rabaan AA, Al-Ahmed SH, Sah R, Al-Tawfiq JA, Al-Qaaneh AM, Al-Jamea LH, Woodman A, Al-Qahtani M, Haque S, Harapan H, Bonilla-Aldana DK, Kumar P, Dhama K, Rodriguez-Morales AJ. Rabaan AA, et al. Hum Vaccin Immunother. 2020 Dec 1;16(12):3011-3022. doi: 10.1080/21645515.2020.1825896. Epub 2020 Nov 6. Hum Vaccin Immunother. 2020. PMID: 33156739 Free PMC article. Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mofijur M, IMR F, Alam MAet al. . Impact of COVID-19 on the social, economic, environmental and energy domains: Lessons learnt from a global pandemic. Sustain Prod Consum 2021 Apr; 26:343–59. doi: 10.1016/j.spc.2020.10.016 Epub 2020 Oct 14. - DOI - PMC - PubMed
    1. Tourism and COVID-19-unprecedented economic impacts. Available at https://www.unwto.org/tourism-and-covid-19-unprecedented-economic-impacts (26 April 2021, date last accessed).
    1. NWTO World Tourism Barometer. Available at https://www.unwto.org/unwto-world-tourism-barometer-data (26 April 21, date last accessed).
    1. COVID-19: Digital green certificates. European Commission. Available at https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/safe-... (26 April 2021, date last accessed).
    1. European Center for Disease Control and Prevention . Interim guidance on the benefits of full vaccination against COVID-19 for transmission and implications for non-pharmaceutical interventions. Available at https://www.ecdc.europa.eu/en/publications-data/interim-guidance-benefit... (accessed 26 April 2021, date last accessed).

Publication types

Substances